AU2010327891A1 - MYBL2 peptides and vaccines containing the same - Google Patents

MYBL2 peptides and vaccines containing the same

Info

Publication number
AU2010327891A1
AU2010327891A1 AU2010327891A AU2010327891A AU2010327891A1 AU 2010327891 A1 AU2010327891 A1 AU 2010327891A1 AU 2010327891 A AU2010327891 A AU 2010327891A AU 2010327891 A AU2010327891 A AU 2010327891A AU 2010327891 A1 AU2010327891 A1 AU 2010327891A1
Authority
AU
Australia
Prior art keywords
peptides
present
cancer
peptide
oligopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2010327891A
Other languages
English (en)
Inventor
Yusuke Nakamura
Ryuji Ohsawa
Takuya Tsunoda
Tomohisa Watanabe
Sachiko Yoshimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of AU2010327891A1 publication Critical patent/AU2010327891A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2010327891A 2009-12-04 2010-12-02 MYBL2 peptides and vaccines containing the same Abandoned AU2010327891A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26687109P 2009-12-04 2009-12-04
US61/266,871 2009-12-04
PCT/JP2010/007028 WO2011067933A1 (en) 2009-12-04 2010-12-02 Mybl2 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
AU2010327891A1 true AU2010327891A1 (en) 2012-06-21

Family

ID=44114795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010327891A Abandoned AU2010327891A1 (en) 2009-12-04 2010-12-02 MYBL2 peptides and vaccines containing the same

Country Status (14)

Country Link
US (1) US20120328638A1 (https=)
EP (1) EP2507257A4 (https=)
JP (1) JP2013512659A (https=)
KR (1) KR20120114284A (https=)
CN (1) CN102753567A (https=)
AU (1) AU2010327891A1 (https=)
BR (1) BR112012013371A2 (https=)
CA (1) CA2782484A1 (https=)
IL (1) IL219927A0 (https=)
MX (1) MX2012006376A (https=)
RU (1) RU2012127762A (https=)
SG (1) SG181108A1 (https=)
TW (1) TW201200525A (https=)
WO (1) WO2011067933A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108623657B (zh) * 2018-05-11 2021-02-12 苏州大学 多肽、重组dna分子、重组载体、外泌体及其应用
AU2024251286A1 (en) * 2023-04-07 2025-10-30 Infinitopes Limited Methods and compositions for cancer treatment using recombinant polypeptides
CN119859688B (zh) * 2025-01-20 2026-03-17 杭州树源生命科学有限公司 环状RNA Hsa_circ_0006332在食管鳞状细胞癌诊断和治疗中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60327786D1 (de) * 2002-09-12 2009-07-09 Oncotherapy Science Inc Kdr-peptide und diese enthaltende impfstoffe
AU2003276167A1 (en) * 2002-10-31 2004-05-25 Janssen Pharmaceutica N.V. Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
ES2364670T3 (es) * 2005-02-25 2011-09-12 Oncotherapy Science, Inc. Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk.
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
TW201200525A (en) 2012-01-01
CA2782484A1 (en) 2011-06-09
BR112012013371A2 (pt) 2016-12-13
SG181108A1 (en) 2012-07-30
EP2507257A4 (en) 2013-04-03
WO2011067933A1 (en) 2011-06-09
JP2013512659A (ja) 2013-04-18
CN102753567A (zh) 2012-10-24
IL219927A0 (en) 2012-07-31
KR20120114284A (ko) 2012-10-16
RU2012127762A (ru) 2014-01-10
MX2012006376A (es) 2012-07-10
US20120328638A1 (en) 2012-12-27
EP2507257A1 (en) 2012-10-10

Similar Documents

Publication Publication Date Title
US20130108664A1 (en) Cdca5 peptides and vaccines including the same
AU2011208271B2 (en) Modified MELK peptides and vaccines containing the same
AU2012265677A1 (en) SEMA5B peptides and vaccines including the same
US20150374810A1 (en) Tomm34 peptides and vaccines including the same
AU2011300253B2 (en) TTLL4 peptides and vaccines containing the same
US8697631B2 (en) TMEM22 peptides and vaccines including the same
AU2011233401B2 (en) ECT2 peptides and vaccines including the same
WO2011067933A1 (en) Mybl2 peptides and vaccines containing the same
US20130287805A1 (en) C18orf54 peptides and vaccines including the same
AU2011319359A1 (en) WDHD1 peptides and vaccines including the same
WO2011125139A1 (en) Cluap1 peptides and vaccines including the same
HK1180003B (en) Ect2 peptides and vaccines including the same
HK1180003A (en) Ect2 peptides and vaccines including the same

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application